Home ⟩ Insights

Insights

rescheduling

2 min read • July 1, 2026

Ascend Wellness Files DEA Applications; The Move Covers Medical Marijuana Dispensaries Across Seven States

DEA Hearings Calendar June July 2026

5 min read • June 29, 2026

The DEA Cannabis Hearing Calendar: Every Key Date Operators Should Know

5 min read • June 29, 2026

DEA Hearings Begin Today: Industry Leaders See Opportunity, but Warn Rescheduling Won’t Solve Everything

2 min read • June 25, 2026

Glass House Brands Lands NYSE Listing, As Cannabis Industry Enters New Era

4 min read • June 25, 2026

Why Data, Insurance, And Proving Cannabis Is Medicine Matter More Than Schedule III

3 min read • June 18, 2026

Glass House Seeks NYSE Listing With New Corporate Structure

4 min read • June 17, 2026

Illinois Lt. Gov. Julianna Stratton Highlights Equity, Economic Impact, and Federal Priorities at Chicago Cannabis Capital Conference

4 min read • June 16, 2026

EXCLUSIVE: Curaleaf CEO Boris Jordan Outlines Path To Institutional Capital

green check verified kevin hart cannabis financing

6 min read • June 9, 2026

The Cannabis Industry Is Entering Its Due Diligence Era: What Does It Mean?

2 min read • June 8, 2026

Cannabis Retailers Get Regulatory Window To Separate Medical Licenses Under New California Rule

3 min read • June 8, 2026

Verano’s George Archos On Navigating A Transformative Year For Cannabis

3 min read • June 4, 2026

Capital Still Flowing Into Cannabis, But Only For Companies That Can Scale

Latest Headlines

7 min read • September 10, 2026

Virginia’s Cannabis Lottery Opens the Market, Capital Determines Who Reaches Opening Day

3 min read • September 10, 2026

Cannabis Operators Keep Schedule III Tax Relief but Lose a Seat in Court

6 min read • September 10, 2026

How a Veteran-Led Cannabis Company Grew 2,342% to Make the Inc. 5000 Twice

5 min read • September 9, 2026

Cannabis Companies Face 15% Loan Rates While 68.1% of Surveyed Hemp Businesses Expect Closure

2 min read • September 9, 2026

Curaleaf Defends Aurora Cannabis Takeover Offer, Challenges Board’s Objections

5 min read • September 8, 2026

How Canopy Growth Is Expanding Beyond Flower in Australia’s 81-Tonne Cannabis Import Market

6 min read • September 8, 2026

Why Exporting Cannabis to Europe Is Harder Than It Looks: Organigram on EU-GMP, Testing and Supply

10 min read • September 7, 2026

Britain Is Finally Ready to Authorize CBD Foods. Europe Could Rewrite the Rules Again

6 min read • September 7, 2026

How EDUN Grew Vape Sales 519% in Colorado’s Shrinking Cannabis Market

3 min read • September 4, 2026

Fatal Oklahoma Cannabis Blast Intensifies Scrutiny Of State Marijuana Regulation

7 min read • September 4, 2026

Cannabis M&A Enters Its Distressed-Asset Era: What Cresco’s $50 Million Pennsylvania Deal Must Deliver

2 min read • September 3, 2026

Aurora CEO On Curaleaf Takeover: ‘It’s Clear Why They Want It,’ But Offer Isn’t Adequate

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.